Once-daily tiotropium Respimat add-on to at least ICS in adult patients with symptomatic asthma: Pooled safety analysis
D. Dusser, R. Buhl, M. Castro, H. Kerstjens, P. Paggiaro, M. Engel, P. Moroni-Zentgraf, A. Unseld, E. Bateman (Paris, France; Mainz, Ingelheim am Rhein, Biberach an der Riss, Germany; St. Louis, United States Of America; Groningen, Netherlands; Pisa, Italy; Cape Town, South Africa)
Source: International Congress 2014 – Asthma and COPD management
Session: Asthma and COPD management
Session type: Thematic Poster Session
Number: 905
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Dusser, R. Buhl, M. Castro, H. Kerstjens, P. Paggiaro, M. Engel, P. Moroni-Zentgraf, A. Unseld, E. Bateman (Paris, France; Mainz, Ingelheim am Rhein, Biberach an der Riss, Germany; St. Louis, United States Of America; Groningen, Netherlands; Pisa, Italy; Cape Town, South Africa). Once-daily tiotropium Respimat add-on to at least ICS in adult patients with symptomatic asthma: Pooled safety analysis. Eur Respir J 2014; 44: Suppl. 58, 905
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: